Pediatrics & Child Health Clinical Trials Update: Week 33, 2026

Published August 14, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

Evaluating Treatment of ADHD in Children With Down Syndrome

This Phase 4 study is looking at how well a stimulant medication works for children who have both Down syndrome and ADHD. Since children with Down syndrome have often been left out of ADHD research, this study may give important information about safe and effective treatment for this group. The trial is recruiting in the United States and aims to enroll 100 children, which could help doctors better support these kids in managing their symptoms.

Research on Body Voice AI Recognition System for Children's Health Management

This study is testing a new voice recognition device that uses artificial intelligence to detect heart, lung, and abdominal illnesses in children. Conditions like congenital heart disease and bronchopneumonia could be identified earlier and without invasive tests, making it easier for doctors to diagnose and treat these issues quickly. The trial is recruiting a large number of participants in China and hopes to improve how children's health is monitored and managed using this technology.

Topical Magnesium Sulfate Versus Peritonsillar Bupivacaine for Post-Tonsillectomy Pain Relief in Children

This Phase 4 trial compares a needle-free magnesium sulfate treatment with the usual bupivacaine injections to relieve pain after tonsil removal surgery in children. If the magnesium option works well, it could provide a less painful and possibly safer way to help kids recover from this common procedure. The study plans to enroll 40 children between 8 and 15 years old and could change how post-surgery pain is managed in pediatric care.

Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia

This Phase 3 trial tested whether giving omega-3 supplements to mothers who are breastfeeding very premature infants could lower the risk of a serious lung condition called bronchopulmonary dysplasia. Although the study was stopped early and did not produce results, the idea behind it was to find a non-invasive way to help fragile newborns avoid lung problems and support healthier development.

The PREVENT AGITATION Trial II - Children ≤1 Year

This study is exploring if one dose of clonidine can prevent emergence agitation, which is when infants wake up confused and upset after surgery. Focusing on babies aged 3 to 12 months, this trial could lead to safer and gentler ways to help young children recover calmly from anesthesia. The trial is recruiting in Australia and Denmark with a goal of 336 participants.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.